How to live long and prosper
To live long and with healthy aging is often associated to the absence of metabolic diseases. However the rise in metabolic diseases in Europe has seen a dramatic surge due to improved life expectancy and lifestyle changes. Studies in animal models to link genetic variations to age-related diseases have failed to clarify the exact function of these gene variants to disease development. Moreover, results from animal models have not been transferable to humans.
The EU-funded research project HUMAN attempts to tackle this fundamental issue by generating ‘humanised’ mouse models with livers and pancreatic beta cells originating from human donors using stem cell technology, making it possible to study the gene functions in human-derived organs. The human cells to be used originate either from patients affected by severe metabolic diseases or from individuals that enjoyed a complete lack of disease and exceptional longevity; 105 years or more.
"By studying these two very different groups, we have a fantastic opportunity to gain further insight into the interplay between genetics and physiology of metabolic diseases and longevity. The results gained might provide tools for individuals to better control their own health and ageing through diet and lifestyle", says project coordinator Associate Professor Knut R. Steffensen.
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.